Document Detail

Treatment of Acute Myeloid Leukemia During Pregnancy: A Systematic Review of the Literature.
MedLine Citation:
PMID:  25258419     Owner:  NLM     Status:  Publisher    
OBJECTIVES: Systematically review the literature assessing outcomes of acute myeloid leukemia (AML) treatment during pregnancy.
DATA SOURCES: A Pubmed literature search (January 1969 to June 2014) for articles written about AML and pregnancy, and bibliographies/citations of previously published reviews.
STUDY SELECTION AND DATA EXTRACTION: Articles written in the English language that administered active AML chemotherapy during pregnancy were included.
DATA SYNTHESIS: Eighty-five fetuses were exposed to chemotherapy from 83 mothers: 8 mothers began induction chemotherapy in the first trimester, 61 mothers in the second trimester, and 14 mothers in the third trimester. Chemotherapy resulted in more fetal deaths and spontaneous abortions during the first trimester (37.5%) compared with the second (9.7%) and third trimesters (0%). All cases included cytarabine; 47 fetuses were exposed to daunorubicin and 8 fetuses to idarubicin. The percentages of fetal defects and death for cytarabine and daunorubicin combinations were 8.5% and 6.4%, respectively. With cytarabine and idarubicin combinations, the percentages of fetal defects and death were 28.6% and 12.5%, respectively. Complete remission (CR) rates were 100%, 81%, and 67% in the first, second, and third trimesters.
CONCLUSIONS: Treatment during the second and third trimesters resulted in fewer fetal complications than the first trimester. However, delaying AML treatment may adversely affect the mother's outcomes. In the reported cases, induction during pregnancy resulted in CR rates comparable to that in nonpregnant patients. The choice of anthracycline is still unclear, but the decision should be made with careful consideration, weighing the outcomes for the mother and fetus.
Abraham Chang; Samit Patel
Related Documents :
11790039 - Reliability in dream research: a methodological note.
25360669 - A case-control study of maternal periconceptual and pregnancy recreational drug use and...
25178359 - Gestational pemphigoid.
25209679 - Endocrinology in pregnancy: bone metabolic changes during pregnancy: a period of vulner...
25226869 - Serial ultrasonographic examination of the fetal thymus in the prediction of early neon...
25330699 - Use and value of ultrasound in diagnosing cesarean scar pregnancy: a report of three ca...
23515619 - The effect of low-moderate dose ethanol consumption on rat mammary gland structure and ...
7468699 - The effect of maternal, labor, and fetal factors upon fetal heart rate during the intra...
20712809 - Immunological paradigms and the pathogenesis of ovine chlamydial abortion.
Publication Detail:
Type:  REVIEW     Date:  2014-9-25
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  -     ISSN:  1542-6270     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-26     Completed Date:  -     Revised Date:  2014-9-27    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© The Author(s) 2014.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diabetes self-management education: acceptability of using trained lay educators.
Next Document:  Ceritinib: A New Tyrosine Kinase Inhibitor for NSCLC.